Reducing the Need for In-Clinic Follow-Up for Medical Abortion in Moldova and Uzbekistan

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01410266
Recruitment Status : Completed
First Posted : August 5, 2011
Last Update Posted : December 3, 2012
Information provided by (Responsible Party):
Gynuity Health Projects

Brief Summary:
The purpose of this study is to determine whether an alternative method of follow-up after medical abortion is acceptable and feasible for use in Moldova and Uzbekistan.

Condition or disease Intervention/treatment Phase
Medical Abortion, Fetus Other: Alternative follow-up Phase 4

Detailed Description:

Medical abortion using mifepristone and misoprostol is a highly effective procedure, but access to it may be impeded by the fact that not all women can afford or want to return for a follow-up visit. This often results in a high loss to follow-up rate. Additionally, with medical abortions of those women who do return for follow-up, higher costs are borne by both the woman and the healthcare system.

This study compares two methods of follow-up after medical abortion: standard of care versus alternative follow-up. The former involves a routine clinic visit two weeks after misoprostol administration. The latter consists of a low-sensitivity pregnancy test and a self-administered questionnaire. Based on the results of the test and questionnaire, women may be flagged as needing in-clinic follow-up or discharged from the study if their abortion is complete.

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 2400 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Health Services Research
Official Title: The Acceptability and Feasibility of Reducing the Need for In-Clinic Follow-Up for First Trimester Medical Abortion in Moldova and Uzbekistan
Study Start Date : September 2010
Actual Primary Completion Date : October 2012
Actual Study Completion Date : October 2012

Arm Intervention/treatment
No Intervention: Standard of care
Standard of care includes a routine clinic visit two weeks after misoprostol administration. At the clinic visit, the woman undergoes a bimanual examination. In the event the woman fails to return for the follow-up visit, clinic procedure is followed for contacting her to determine abortion status and the need for further intervention, if any.
Active Comparator: Alternative follow-up
At a clinic visit, before mifepristone administration, the woman completes a semi-quantitative pregnancy test. After mifepristone administration, she is provided with another pregnancy test and a checklist to be self-administered two weeks after she takes misoprostol. On an assigned date, the woman is contacted by phone by the clinic staff and asked to report on the results of both tests. The provider then confirms whether, based on the woman's responses, she should return for a follow-up visit.
Other: Alternative follow-up
Alternative follow-up consists of a self-administered semi-quantitative pregnancy test designed to measure urine beta-hCG levels, and a self-administered questionnaire consisting of 7 questions. Results of both are reviewed by the provider to determine if in-clinic follow-up is needed.
Other Names:
  • semi-quantitative pregnancy test
  • self-administered questionnaire

Primary Outcome Measures :
  1. Continued, ongoing pregnancy [ Time Frame: 1 month ]

Secondary Outcome Measures :
  1. Percentage of women who return for follow-up [ Time Frame: 1 month ]
  2. Percentage of women receiving other treatment for ongoing pregnancy [ Time Frame: 1 month ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   16 Years to 55 Years   (Child, Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Reproductive-age woman seeking a medical abortion
  • Woman in good general health
  • Woman with an intrauterine pregnancy less than or equal to 63 days gestation on the day of mifepristone administration
  • Woman able and willing to sign consent forms
  • Woman eligible for medical abortion according to clinician's assessment
  • Woman agreeing to be followed up with, by phone or at a clinic visit

Exclusion Criteria:

  • Woman with a pregnancy greater than 63 days gestation on the day of mifepristone administration

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01410266

Moldova, Republic of
The Perinatalogy Center
Balti, Moldova, Republic of
Municipal Clinical Hospital
Chisinau, Moldova, Republic of
The National Center of Reproductive Health and Medical Genetics
Chisinau, Moldova, Republic of
The Center of Women Health "Ana"
Drochia, Moldova, Republic of
Clinic #2 of Tashkent Medical Academy
Tashkent, Uzbekistan
Municipal Maternity House #10
Tashkent, Uzbekistan
Women's Wellness Center
Tashkent, Uzbekistan
Sponsors and Collaborators
Gynuity Health Projects
Principal Investigator: Hillary J. Bracken, PhD, MHS, MA Gynuity Health Projects
Principal Investigator: Beverly Winikoff, MD, MPH Gynuity Health Projects

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Gynuity Health Projects Identifier: NCT01410266     History of Changes
Other Study ID Numbers: 6.5
First Posted: August 5, 2011    Key Record Dates
Last Update Posted: December 3, 2012
Last Verified: November 2012

Keywords provided by Gynuity Health Projects:
medical abortion
first trimester
pregnancy test